Role of p53 in drug resistance in ovarian cancer
Lancet
.
1997 Mar 15;349(9054):744-5.
doi: 10.1016/S0140-6736(05)60195-X.
Author
A N Shelling
1
Affiliation
1
National Women's Hospital, Auckland, New Zealand.
PMID:
9074569
DOI:
10.1016/S0140-6736(05)60195-X
No abstract available
MeSH terms
Apoptosis / genetics
Drug Resistance, Neoplasm / genetics
Female
Genes, p53 / genetics*
Humans
Mutation
Ovarian Neoplasms / drug therapy*
Ovarian Neoplasms / genetics*
Prognosis